These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32293304)
1. Improving the diagnosis of common parotid tumors via the combination of CT image biomarkers and clinical parameters. Zhang D; Li X; Lv L; Yu J; Yang C; Xiong H; Liao R; Zhou B; Huang X; Liu X; Tang Z BMC Med Imaging; 2020 Apr; 20(1):38. PubMed ID: 32293304 [TBL] [Abstract][Full Text] [Related]
2. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland. Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128 [TBL] [Abstract][Full Text] [Related]
3. An ultrasound-based ensemble machine learning model for the preoperative classification of pleomorphic adenoma and Warthin tumor in the parotid gland. He Y; Zheng B; Peng W; Chen Y; Yu L; Huang W; Qin G Eur Radiol; 2024 Oct; 34(10):6862-6876. PubMed ID: 38570381 [TBL] [Abstract][Full Text] [Related]
4. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors. Razek AAKA Magn Reson Imaging; 2019 Nov; 63():55-59. PubMed ID: 31422165 [TBL] [Abstract][Full Text] [Related]
5. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland. Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of salivary gland tumors through tumor heterogeneity: a comparison between pleomorphic adenoma and Warthin tumor using CT texture analysis. Jung YJ; Han M; Ha EJ; Choi JW Neuroradiology; 2020 Nov; 62(11):1451-1458. PubMed ID: 32621023 [TBL] [Abstract][Full Text] [Related]
7. Discriminating atypical parotid carcinoma and pleomorphic adenoma utilizing extracellular volume fraction and arterial enhancement fraction derived from contrast-enhanced CT imaging: A multicenter study. Xu ZY; Huang LW; Yang YJ; Cai ZP; Chen ML; Lu RL; Ouyang YX; Hong ZK; Huang WJ; Xu ZF Cancer Med; 2024 Jun; 13(12):e7407. PubMed ID: 38899534 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors. Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491 [TBL] [Abstract][Full Text] [Related]
9. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images. Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615 [TBL] [Abstract][Full Text] [Related]
10. Application of DTI and ARFI imaging in differential diagnosis of parotid tumours. Yu J; Du Y; Lu Y; Zhang W; Zhang D; Wang G; Li C Dentomaxillofac Radiol; 2016; 45(6):20160100. PubMed ID: 27351345 [TBL] [Abstract][Full Text] [Related]
11. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings. Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073 [TBL] [Abstract][Full Text] [Related]
12. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid. Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of CT perfusion imaging for parotid neoplasms. Dong Y; Lei GW; Wang SW; Zheng SW; Ge Y; Wei FC Dentomaxillofac Radiol; 2014; 43(1):20130237. PubMed ID: 24186883 [TBL] [Abstract][Full Text] [Related]
14. JOURNAL CLUB: The Warthin Tumor Score: A Simple and Reliable Method to Distinguish Warthin Tumors From Pleomorphic Adenomas and Carcinomas. Wang CW; Chu YH; Chiu DY; Shin N; Hsu HH; Lee JC; Juan CJ AJR Am J Roentgenol; 2018 Jun; 210(6):1330-1337. PubMed ID: 29667889 [TBL] [Abstract][Full Text] [Related]
15. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors. Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of parotid gland tumors with contrast-enhanced ultrasound. Fischer T; Paschen CF; Slowinski T; Alkhameri A; Berl JC; Klingebiel R; Thomas A Rofo; 2010 Feb; 182(2):155-62. PubMed ID: 19862655 [TBL] [Abstract][Full Text] [Related]
17. Enhanced CT combined with texture analysis for differential diagnosis of pleomorphic adenoma and adenolymphoma. Xia F; Guo F; Liu Z; Zeng J; Ma X; Yu C; Li C BMC Med Imaging; 2023 Oct; 23(1):169. PubMed ID: 37891554 [TBL] [Abstract][Full Text] [Related]
18. Multispectral optoacoustic tomography of benign parotid tumors in vivo: a prospective observational pilot study. Kouka M; Waldner M; Guntinas-Lichius O Sci Rep; 2024 May; 14(1):10597. PubMed ID: 38719924 [TBL] [Abstract][Full Text] [Related]
20. Correlation between computed tomography imaging and histopathology in pleomorphic adenoma of parotid gland. Kim H; Kim SY; Kim YJ; Ko JM; Park MJ; Kim JH; Hah JH; Kwon TK; Kim KH; Sung MW Auris Nasus Larynx; 2018 Aug; 45(4):783-790. PubMed ID: 29055657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]